Jinxia Wang - Shandong Weigao Independent Non-Executive Director

SHWGF Stock  USD 0.96  0.00  0.00%   

Director

Mrs. Wang Jin Xia is an Independent NonExecutive Director of Shandong Weigao Group Medical Polymer Company Limited. Mrs. Wang is a senior economist and has over 30 years of working experience especially the management experience in the pharmaceutical commerce pharmaceutical and healthcare products industry. Mrs. Wang obtained a bachelor degree in economics from Dongbei University of Finance and Economics in July 1983 and was assigned to work in State Pharmaceutical Administration of China Pharmaceutical Company. Mrs. Wang was deputy director of the finance division deputy director and director of the information division of China Pharmaceutical Company during the period from 1989 to 2002 and deputy secretary of China Pharmaceutical Business Association in 1999. Mrs. Wang was an independent director of Jiangsu Wu Zhong Industrial Company Limited a company listed in Shanghai from April 2002 to April 2010. Mrs. Wang held the positions of the general secretary and the vice president of China Association of Pharmaceutical Commerce and the person in charge of the pharmaceutical chains branch of China Association of Pharmaceutical Commerce from 2000 to 2012. She is also a senior advisor of China Nonprescription Medicines Association. Mrs. Wang is also an independent nonexecutive director of Shanghailisted Merro Pharmaceutical Co. Ltd since September 2007 and also the independent non executive director of Shandong Realcan Pharmaceutical Co. Ltd. a company listed in Shenzhen since November 2009. since 2012.
Age 60
Tenure 12 years
Phone86 63 1562 1999
Webhttps://www.weigaogroup.com
Wang obtained a bachelor degree in economics from Dongbei University of Finance and Economics in July 1983. Mrs. Wang was deputy director of the finance division, deputy director and director of the information division of China Pharmaceutical Company during the period from 1989 to 1995, chairperson and general manager of Beijing Zhongxinli Pharmaceutical Consultancy Company from 1996 to 1997, deputy secretary of China Pharmaceutical Business Association from 1998 to 1999, committee member of the drug encoding division of the State of Food and Drug Administration. Mrs. Wang was an independent director of Jiangsu a Shanghailisted Wu Zhong Industrial Company Limited from April 2002 to April 2010. Mrs. Wang is currently the vice president of China Association of Pharmaceutical Commerce and the president of the pharmaceutical chains branch of China Association of Pharmaceutical Commerce

Shandong Weigao Management Efficiency

The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Shandong Weigao's management efficiency ratios could be used to measure how well Shandong Weigao manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 3.46 B in total debt with debt to equity ratio (D/E) of 0.2, which may suggest the company is not taking enough advantage from borrowing. Shandong Weigao Group has a current ratio of 2.93, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Shandong Weigao until it has trouble settling it off, either with new capital or with free cash flow. So, Shandong Weigao's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Shandong Weigao Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Shandong to invest in growth at high rates of return. When we think about Shandong Weigao's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Peter HenryCitigroup
51
Christopher JonesBecton Dickinson And
65
Amal JohnsonIntuitive Surgical
65
Andrew EckertBecton Dickinson And
56
Malcolm PradhanAlcon AG
N/A
Josh PuckridgeAlcon AG
N/A
Thomas BahenAlcon AG
N/A
Bertram ScottBecton Dickinson And
69
Marshall LarsenBecton Dickinson And
72
Mark RubashIntuitive Surgical
61
Luis HueteAlcon AG
N/A
Carlos ToledoAlcon AG
N/A
Rebecca RimelBecton Dickinson And
69
Willard OverlockBecton Dickinson And
71
Craig BarrattIntuitive Surgical
55
Amy LaddIntuitive Surgical
N/A
Ignacio LopezAlcon AG
N/A
Leslie IrelandCitigroup
58
Gavin WatesAlcon AG
N/A
Claire PomeroyBecton Dickinson And
65
Edward DeGraanBecton Dickinson And
70
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the Peoples Republic of China. The company was incorporated in 2000 and is based in Weihai, the Peoples Republic of China. Shandong Weigao operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 11476 people. Shandong Weigao Group [SHWGF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Shandong Weigao Group Leadership Team

Elected by the shareholders, the Shandong Weigao's board of directors comprises two types of representatives: Shandong Weigao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Weigao's management team and ensure that shareholders' interests are well served. Shandong Weigao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Weigao's outside directors are responsible for providing unbiased perspectives on the board's policies.
Junqiang Lu, Ex Director
Jia Li, Independent Non-Executive Director
Miu Wong, Company Secretary
Hong Ju, Vice-General Manager of the Production and Supply Chain
Hua Zhang, Vice Chairman, General Manager, Compliance Officer and Chairman of Corporate Governance Committee
Shu Zhou, Non-Executive Director
Jian Gong, Executive Director
Rinan Cong, CEO Director
Yi Wang, Deputy General Manager of General Affairs and Executive Director
Ming Fu, Independent Non-Executive Director
Jin Cui, CFO
Jinxia Wang, Independent Non-Executive Director
Jin Wang, Independent Non-Executive Director
Shili Ni, Ex Director
Xiu Song, Head - Sales Department
Wai Lo, Independent Non-Executive Director
Yuk Chan, Head - Business Development & Investor Relations
Xue Chen, Non-Executive Chairman of the Board
Lie Xia, Executive Director
De Zhou, Deputy General Manager - Blood Transfusion Division
Xue Wu, Chief Officer
Jing Long, Vice-General Manager of Marketing Management

Shandong Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shandong Weigao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shandong Weigao Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Shandong Weigao Group information on this page should be used as a complementary analysis to other Shandong Weigao's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Shandong Pink Sheet analysis

When running Shandong Weigao's price analysis, check to measure Shandong Weigao's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Weigao is operating at the current time. Most of Shandong Weigao's value examination focuses on studying past and present price action to predict the probability of Shandong Weigao's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Weigao's price. Additionally, you may evaluate how the addition of Shandong Weigao to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Please note, there is a significant difference between Shandong Weigao's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shandong Weigao is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shandong Weigao's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.